Ethyl (S)-2,4-Diaminobutanoate{7,12-bis[1-(1,4,7,10,13-pentaoxatetradecyl)ethyl]-3,8,13,17-tetramethylporphyrin-2,18-dipropionato}platinum (II)

ID: ALA2068411

Max Phase: Preclinical

Molecular Formula: C58H84N6O16Pt

Molecular Weight: 1316.41

Molecule Type: Unknown

Alternative Forms

1. Parent:

   

   ALA2068411

   Platinum complex

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1316.41

Molecular Weight (Monoisotopic): 1315.5592

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Lottner C, Bart KC, Bernhardt G, Brunner H..  (2002)  Hematoporphyrin-derived soluble porphyrin-platinum conjugates with combined cytotoxic and phototoxic antitumor activity.,  45  (10): [PMID:11985474] [10.1021/jm0110688]

Source

Source(1):

• Scientific Literature